{"news_desk": "Business", "print_page": "4", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "Drug maker Shire reveals that its $30 billion takeover offer for Baxalta was rebuffed in July; revelation is seen as effort to put additional pressure on biopharmaceutical company to come to negotiating table. ", "type_of_material": "News", "word_count": "634", "lead_paragraph": "Baxalta rebuffed the approach, saying the offer \u201csignificantly undervalues\u201d the company.", "pub_date": "2015-08-05T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Shire\u2019s Offer to Buy Drug Maker Baxalta for $30 Billion Is Rebuffed", "print_headline": "Shire&#8217;s $30 Billion Offer for Maker of Drugs for Rare Diseases Is Rebuffed "}, "snippet": "Baxalta rebuffed the approach, saying the offer \u201csignificantly undervalues\u201d the company.", "multimedia": [{"height": 126, "url": "images/2015/08/05/business/db-shire-web1/db-shire-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/08/05/business/db-shire-web1/db-shire-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 394, "url": "images/2015/08/05/business/db-shire-web1/db-shire-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "394", "xlarge": "images/2015/08/05/business/db-shire-web1/db-shire-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/08/05/business/db-shire-web1/db-shire-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/08/05/business/db-shire-web1/db-shire-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/08/05/business/dealbook/shire-offers-to-buy-drug-maker-baxalta-for-30-billion.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Shire PLC", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Baxalta Inc.", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Ornskov, Flemming", "name": "persons"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "55c0af5938f0d85dffa32d75", "source": "The New York Times"}